Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP223257.RA80qC8CiDJVDxE1nqlMQ6FmSNLooNXXAjUaW7m03l2ss130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP223257.RA80qC8CiDJVDxE1nqlMQ6FmSNLooNXXAjUaW7m03l2ss130_assertion type Assertion NP223257.RA80qC8CiDJVDxE1nqlMQ6FmSNLooNXXAjUaW7m03l2ss130_head.
- NP223257.RA80qC8CiDJVDxE1nqlMQ6FmSNLooNXXAjUaW7m03l2ss130_assertion description "[Combined with abdominal obesity, epistasis in the VLDL pathway (lipoprotein lipase, apolipoprotein CIII, hepatic lipase, PPARalpha, PPARgamma, and apo E genes) has a deleterious effect on fasting triglycerides and coronary artery disease risk profile ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP223257.RA80qC8CiDJVDxE1nqlMQ6FmSNLooNXXAjUaW7m03l2ss130_provenance.
- NP223257.RA80qC8CiDJVDxE1nqlMQ6FmSNLooNXXAjUaW7m03l2ss130_assertion evidence source_evidence_literature NP223257.RA80qC8CiDJVDxE1nqlMQ6FmSNLooNXXAjUaW7m03l2ss130_provenance.
- NP223257.RA80qC8CiDJVDxE1nqlMQ6FmSNLooNXXAjUaW7m03l2ss130_assertion SIO_000772 17342071 NP223257.RA80qC8CiDJVDxE1nqlMQ6FmSNLooNXXAjUaW7m03l2ss130_provenance.
- NP223257.RA80qC8CiDJVDxE1nqlMQ6FmSNLooNXXAjUaW7m03l2ss130_assertion wasDerivedFrom lhgdn-20090331 NP223257.RA80qC8CiDJVDxE1nqlMQ6FmSNLooNXXAjUaW7m03l2ss130_provenance.
- NP223257.RA80qC8CiDJVDxE1nqlMQ6FmSNLooNXXAjUaW7m03l2ss130_assertion wasGeneratedBy ECO_0000203 NP223257.RA80qC8CiDJVDxE1nqlMQ6FmSNLooNXXAjUaW7m03l2ss130_provenance.